DDAH2 polyclonal Antibody | BS90397

DDAH2 polyclonal Antibody | BS90397 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human, Mouse, Rat

Application: WB IP

Application Range: WB:1:2,000-1:5,000 IP:1:10-:50

Background: DDAH, a dimethylarginine dimethylaminohydrolase, hydrolyzes dimethyl arginine (ADMA) and monomethyl arginine (MMA), both inhibitors of nitric oxide synthases, and may be involved in in-vivo modulation of nitric oxide production. Impairment of DDAH causes ADMA accumulation and a reduction in cGMP generation. DDAH II, the predominant DDAH isoform in endothelial cells, facilitates the induction of nitric oxide synthesis by all-trans-Retinoic acid (atRA) . DDAH proteins are highly expressed in colon, kidney, stomach and liver tissues.

Storage & Stability: Store at +4°C after thawing. Aliquot store at -20°C. Avoid repeated freeze / thaw cycles.

Specificity: DDAH2 polyclonal Antibody detects endogenous levels of DDAH2 protein.

Molecular Weight: 30kDa

Note: For research use only, not for use in diagnostic procedure.

Alternative Names: DDAH-2, Dimethylarginine dimethylaminohydrolase 2, DDAH2, DDAH, G6A, NG30, DDAH, DDAH II, DDAH-2, DDAH2, DDAH2, DDAHII, Dimethylargininase 2, Dimethylargininase-2, Dimethylarginine dimethylaminohydrolase 2, Dimethylarginine dimethylaminohydrolase II, G6a, N (G), N (G) -dimethylarginine dimethylaminohydrolase 2, NG dimethylarginine dimethylamino hydrolase homolog, NG30, OTTHUMP00000029307, OTTHUMP00000029310, OTTHUMP00000174488, OTTHUMP00000174489, Protein G6a, S phase protein, S-phase protein,

Immunogen: Synthetic peptide within Human DDAH2 aa 1-100

Conjugate: Unconjugated

Modification: Unmodification

Purification & Purity: ProA affinity purified

Pathway: